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Abstract: It is known that intake of dietary fatty acid (FA) is strongly correlated with prostate
cancer progression but is highly dependent on the type of FAs. High levels of palmitic acid (PA) or
arachidonic acid (AA) can stimulate the progression of cancer. In this study, a unique experimental
set-up consisting of a Raman microscope, coupled with a commercial shear-flow microfluidic system
is used to monitor fatty acid uptake by prostate cancer (PC-3) cells in real-time at the single cell level.
Uptake of deuterated PA, deuterated AA, and the omega-3 fatty acids docosahexaenoic acid (DHA)
and eicosapentaenoic acid (EPA) were monitored using this new system, while complementary flow
cytometry experiments using Nile red staining, were also conducted for the validation of the cellular
lipid uptake. Using this novel experimental system, we show that DHA and EPA have inhibitory
effects on the uptake of PA and AA by PC-3 cells.
Keywords: Raman spectroscopy; single cell analysis; prostate cancer; fatty acids; microfluidic device
1. Introduction
It has been known for many years that metabolic reprogramming, resulting in increased production
of intermediates for the synthesis of proteins, nucleic acids and lipids, is a well-established signature
of cancer development [1,2]. This process is a prerequisite for cells to break-free from the primary
tumour, survive in an energy/nutrient deficient environment, and migrate to a metastatic niche [3–6].
Within the last decade or so, it has become increasingly clear that the function of cellular lipids is
not just energy storage, but these biomolecules play a crucial role in cellular regulation associated
with cancer progression. Cells in healthy mammalian tissues satisfy their lipid requirements through
the uptake of fatty acids (FAs) from the bloodstream and this is an important and tightly controlled
process [7]. Metabolic reprogramming initiates a shift in the balance between exogenous FA uptake
and de novo FA synthesis. The deregulation of FA uptake in cancer metabolism and consequences for
cancer progression; however, are still not well understood [8,9].
FA metabolism is a complex and dynamic process and there is a real need to develop new
analytical methodologies that enable the study of such systems in real time under changing dynamic
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flow conditions. Uptake studies have been carried out using a range of biological assays including
fluorescent imaging [10]. Fluorescent labels can either be general or specific for a given FA, but the use
of such labels is not always straightforward since the label itself can affect the uptake and biochemical
activity of the labelled molecule [11]. Detailed chemical information can potentially be gained from
mass spectrometry (MS)-based studies but typical lipidomic experiments involve both extraction of
lipids from the biological sample and chromatographic separation prior to analysis [12]. Importantly,
MS-based lipidomic experiments cannot be done at the single cell level and although single cell lipid
imaging using time of flight secondary ion mass spectrometry (ToF-SIMS) can be achieved, it is not
high throughput and generally only images from a few cells are reported [13]. More recently, studies
have been carried out using optical techniques such as infrared (IR) or Raman spectroscopy. Unlike
MS, these methods are non-destructive and can measure the overall global biochemistry of a sample
on a cell by cell basis. FA uptake studies have mostly sampled fixed time points under static rather
than dynamic flow conditions [14–17]. Infrared studies by Gazi et al. followed the uptake of both
deuterated arachidonic and palmitic acid but the samples were analysed after being fixed and dried
since strong IR absorption by water significantly hinders live cell analysis [14]. Raman spectroscopy
is more suited to the study of cells in aqueous environments since the water gives a relatively weak
Raman spectrum. Lipid molecules modified with an alkyne tag have been employed to the study
specific lipid uptake [17–19]. The alkyne tag can show a much higher Raman signal intensity in the
spectra and hence enables easier monitoring of the uptake of the tagged molecule. The uptake and
metabolism of fatty acid molecules, however, are highly sensitive to structure changes, which raises a
question of whether the tagging could affect the metabolic pathway [20].
To study FA uptake under more realistic conditions it is desirable to couple spectroscopy with
a microfluidic device such that real time measurements under dynamic/switchable conditions can
be measured. Coupling Raman to a dynamic flow system is a relatively new development and has
been used to investigate several biological systems including identification of circulating tumour
cells, drug cell interaction and lipid uptake [21–25]. Most studies use surface enhanced Raman
spectroscopy (SERS) to increase the sensitivity of the system but again the addition of the SERS
tag to the molecule in question has the potential to influence the outcome. Often these studies use
home-made bespoke microfluidic devices that are tailored specifically to a given task and are thus
not readily available [21–25]. In the work presented here, a commercially available shear-flow assay
system (BioFlux200, Fluxion Biosciences Inc., Ca, USA) is used to provide a dynamic flow environment
coupled to a Raman microspectrometer. This represents the first demonstration of this particular
combination of instrumentation. In this study, we use the prostate cancer cell line PC-3 to monitor the
uptake of various fatty acids.
Prostate cancer (PCa) is the third most common cancer in the UK and the second most common
cause of cancer death among men [26]. Metastases to the bone marrow stroma (BMS), a rich source
of lipids stored within adipocytes, is the main cause of morbidity and mortality in PCa patients.
Several studies have demonstrated how dietary fatty acids relate to the progression of PCa and in
recent years, it has been shown that specific types of FAs have a particularly detrimental effect on
patient outcome [27–29]. Moreover, research has shown a strong correlation between different types
of dietary fatty acids (FAs) intake and PCa progression, where high-levels of palmitic acid (PA) and
arachidonic acid (AA) intake tend to have a greater impact on cancer behaviour [27–29]. Brown et al.,
however, found that omega-3 polyunsaturated fatty acids (PUFAs) can induce inhibitory effects on
the uptake of AA [30]. This finding has implications for competitive lipid uptake between different
types FAs. In the work reported here, isotopically labelled FAs (deuterated palmitic acid (D31-PA) and
deuterated arachidonic acid (D8-AA)) were used in combination with two non-deuterated omega-3
PUFAs, docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) to study competitive uptake in
PC-3 cells.
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2. Results
2.1. Example Cell Spectra
Raman spectra of PC3 cells exposed to D31-PA were acquired from 671 to 2430 cm−1 within
which 1900-2400 cm−1 is the CD stretching region for monitoring the uptake of the deuterated FAs [31].
During the measurement, each single cell was targeted individually with the Raman beam. Example
microscope image of cells can be found in the Section Appendix A.1. Figure 1a,b shows examples of all
the mean spectra at each time point over full spectrum range and CD stretching region respectively for
the cells treated with D31-PA only under normoxic condition (oxygen concentration in a normoxic
incubator is 18.6%, at sea level [32]). Figure 1c shows the mean spectra of the 2106 cm−1 peak
(2082–2136 cm−1) used for monitoring the D31-PA uptake.
Figure 1. Example mean cell spectra at each time point (PC-3 Cells treated with D31-PA under normoxic
condition) with different Raman shift ranges. (a) Full range mean cell spectrum. This contains both
the cell information and the CD signal acquired in the ‘silent region’. (b) Mean spectra in the CD
stretching region (1900–2400 cm−1) zoomed in from (a). This contains the whole CD stretch spectral
envelope from the D31-PA. (c) Mean spectra of the 2106 cm−1 CD peak used (2082–2136 cm−1). This is
the Raman shift region that was used for relative quantification of the D31-PA uptake by the PC-3 cells
by calculating the areas under the curve in this study.
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As shown in Figure 1b, the baseline of the CD stretching region is not flat which means the
background signal was not able to be removed completely. Nevertheless, the symmetric –CD2 stretching
(νsCD2) signal from D31-PA can be clearly detected at 2106 cm−1. Figure 1c shows just the region
2082-2136 cm−1 with a linear baseline correction. The areas under these curves were subsequently
used for monitoring the relative, rather than absolute, D31-PA uptake.
2.2. Competative Fatty Acid Uptake.
Areas under the νsCD2 peak were calculated for each cell to monitor the relative D31-PA
competitive uptake. D31-PA is the only isotopically tagged material used in the treatment and all
Raman spectra were acquired from cells in pure DPBS. Therefore, the νsCD2 peak at 2106 cm−1 indicates
only D31-PA uptake by the cells. Figure 2 shows and example box and whisker plot for cells treated
with D31-PA under normoxic conditions. The trend plot shows that there is a continuous increase in
the D31-PA uptake as a function of exposure. There is, however, significant variation in the amount of
D31-PA taken up by individual cells as a function of time, indicative of cell population heterogeneity.
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Figure 2. Example box-and-whisker plot for cells treated with D31-PA only under normoxic state and
the control experiment. On each box, the central line is the median while the edges of the box are the
25th and 75th percentiles. The whiskers extend to the most extreme data points that are not outliers
(within ~99.3% of the data boundary), and the outliers are plotted individually as cross marks.
Figure 3a shows competitive fatty acid uptake under normoxic conditions. Please note that the
heterogeneity in uptake is similar to that observed in Figure 2, but for visual clarity just the trend
lines are shown. The cells treated with D31-PA alone have the highest uptake rates (the red line). The
trend line suggests that the uptake of D31-PA started as soon as the treatment was administered and a
notable increase of D31-PA signal can be seen 45 min post treatment. This uptake remains at a high rate
but starts to slow down after 90 min. After 24 h of treatment, the uptake of D31-PA was still on-going
but at a slower rate.
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Figure 3. Lipid uptake experiments under both normoxic and hypoxic conditions. (a) Trend lines
linking the means for the D31-PA uptake by cells for the experiments carried out under normoxic
conditions from t = 0 to t = 1440 min. (b) Trend lines linking the means of the D31-PA uptake by cells
treated with D31-PA alone under normoxic and hypoxic states from t = 0 to t = 1440 min. Please note
that (i) for display purposes there is a discontinuity of the time axes between 180 and 1440 min and (ii)
the trend lines in (a,b) are only a guide for the eye.
Lipid competition experiments were carried out by treating the cells with D31-PA and one other FA:
DHA, EPA or D8-AA under normoxic conditions. The trend lines of the lipid competition experiments
are also plotted in Figure 3a where suppression of the uptake of D31-PA by the PC-3 cells due to the
presences of DHA, EPA or D8-AA can be seen to varying degrees. Since D31-PA is the only reagent
used that will give signal at the 2106 cm−1 νsCD2 peak, inhibitory effects on the D31-PA uptake by
omega-3 FAs can be reflected if a lower rate of uptake of D31-PA is observed. There are no significant
uptake differences between all experiments in the first 45 min of treatment, yet suppression of the
D31-PA uptakes by DHA, EPA and D8-AA were observed from t = 60 min. This suppression effect can
be seen throughout the rest of the time points in the EPA and D8-AA experiments. However, cells
treated with D31-PA and DHA behave differently compared to the other experiments. Although it
was expected that DHA will have the similar suppression effects on the uptake of D31-PA by the PC-3
cells, the results suggest DHA reduces uptake but it is not as effective as similar concentrations of AA
or EPA.
Data show the suppression of D31-PA uptake in the presence of D8-AA under normoxic conditions,
suggestive of the essential nature of AA in contrast to the non-essential PA. In Figure 3a, however, the
uptake trend of D31-PA by the cells treated with D31-PA only is slightly different to other cases. The
uptake of D31-PA maximises at t = 180 min and starts decreasing afterwards in the lipid competition
experiment with D8-AA, where the uptake of D31-PA gradually increases after t = 180 min in other
cases. It is believed this phenomenon is related to the cellular adaptation to the environment.
The coupled system used in this study can also be used for studying similar mechanisms under
different conditions. To demonstrate this flexibility, uptake of D31-PA by PC-3 cells was also monitored
under chemically induced hypoxic conditions. The majority of the research into the relationship
between the progression of PCa and dietary FAs are carried out under the “normoxic” atmospheric
conditions. However, it has been reported that many prostate tumour lesion are hypoxic, with an
average pO2 of 6.7 mm Hg as compared with blood (75–100 mm Hg) and muscle (30 mm Hg) [33].
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These changes in conditions may affect the metabolism of cells but not necessarily make any difference
to the uptake of lipids. The trends for the uptake of D31-PA under normoxic and hypoxic conditions
are compared in Figure 3b and the result suggests that the uptake of D31-PA by PC-3 cells under
hypoxic condition started earlier than cells under normoxic conditions. D31-PA signal can be detected
at 15 min of treatment and continues to increase until reaching a maximum at 180 min. The trend of
the uptake of D31-PA under hypoxia drops at 24 h.
All results have been statistically tested by comparing the D31-PA uptake by cells treated under
normoxic conditions with the competition experiments using the two-tailed t-test. The relative
information and statistical results can be found in Table 1. The null hypothesis is that the uptake of
D31-PA by PC-3 cells stays the same under different conditions. The p value for each case was calculated
and any p value that is greater than the critical value of 0.05 or 0.01 will reject the null hypotheses,
i.e., there are significant differences between the two sets of data. Table 1 shows the calculated p
values for all cases at each time point. The results show that the uptake of D31-PA is supressed when
omega-3 fatty acids were administered to the cells along with the D31-PA. Furthermore, a significant
difference of D31-PA uptake between the control experiment and the cells treated with D31-PA only
was observed.
Table 1. The p values of the two-tailed t-tests comparing the D31-PA uptake of cells treated with
D31-PA-only and other treatments. * is significant at 0.05 confidence level and ** is at 0.01 confidence
level. n values are shown in the brackets.
p Value D31-PA Only (Normoxic State)
0 min 15 min 30 min 45 min 60 min 90 min 180 min 1440 min
vs. DHA 0.999(98)
0.999
(89)
0.254
(91)
0.023
(95) *
0.999
(89)
<0.001
(87) **
<0.001
(81) **
0.144
(91)
vs. EPA 1.000(99)
0.043
(94) *
<0.001
(91) **
<0.001
(90) **
<0.001
(93) **
<0.001
(91) **
<0.001
(92) **
<0.001
(91) **
vs. AA 0.987(96)
0.933
(100)
0.690
(93)
0.964
(98)
<0.001
(93) **
<0.001
(99) **
<0.001
(85) **
<0.001
(93) **
vs. D31-PA
(Hypoxic)
0.918
(99)
1.000
(97)
1.000
(90)
1.000
(96)
0.901
(96)
0.016
(94) *
0.871
(92)
0.010
(93) *
vs. control 0.998(98)
0.012
(93) *
<0.001
(92) **
<0.001
(94) **
<0.001
(95) **
<0.001
(95) **
<0.001
(93) **
<0.001
(91) **
Further Student’s t-tests were performed on the data to confirm that there are statistical differences
of the D31-PA νsCD2 peak area, between the experiments using untreated and treated cells. The table
showing the p values and further information can be found in Section Appendix A.3.
2.3. Distribution of Data Points
It was observed that there are larger variances in D31-PA uptake between cells at later time points.
This is unlikely to be caused by the system’s stability, as the system had been tested non-biologically
with polystyrene beads (details can be found in Section 4.1.3). To rule out a relationship between the
variance in measured uptake and the position in the sequence of 45 cell measurements, the relationship
between the areas under the νsCD2 peak and the corresponding sequence number was investigated for
three time points. As can be seen in Figure A2a–c, no trend exists between the level of uptake and the
order in which the cells were measured
A more likely cause of variation in the data is the localisation of lipid droplets within the
cells [34,35]. The Raman laser spot size is smaller than the whole cell, so it is possible that large
differences will be seen if the Raman laser hits a lipid droplet rather than an area with low lipid
concentration. To investigate this, cells were treated with 20 µM D31-PA but in this case five spectra
were obtained for each cell at different locations, which means that the whole cell was completely
sampled, see Figure A2d,e.
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The areas under the peaks measured at the five locations in each cell are different, reflecting the
localisation of the lipid droplets. This may be one of the contributions to the large variance observed at
later time points in the lipid uptake experiments, where the Raman laser might have just hit or missed
the lipid droplet. In addition to the variations within each cell, variations between different cells were
also observed.
3. Discussion
In this study, the BioFlux microfluidic system was coupled with a Raman microspectrometer for
the first time, and therefore several system optimisation and method development experiments were
required. Cells had to be seeded into the microfluidic device before performing any experiments.
Coatings, such as poly L-lysine or fibronectin, are widely employed for improved cell attachment
in microfluidic channels [36,37]. Although the coating is only a monolayer of molecules, it may still
be detected by Raman spectroscopy, which is undesired. Therefore, it was decided to pre-seed the
cells for 2 days in uncoated wells before starving so that the cells had enough time to settle down and
attach. Cells seeded with this method allowed us to perform the experiments with no significant cell
detachment at a sheer flow rate of 0.15 dyn cm−2.
To ensure a consistent FA baseline, serum-free media was used in the FA uptake experiments. This
is because serum-containing culture media will lead to a reduction in the D31-PA uptake compared
with cells cultured in serum-free medium, specifically due to the presence of foetal calf serum (FCS)
which contains a range of FAs [38]. A FA treatment concentration of 20 µM was selected based on
the study by Brown et al., which suggested that cell viability decreases in the presence of FA at a
concentration greater than 50 µM [30]. In the work present here, a total FA concentration of either
20 µM (single FA), or 40 µM (competitive uptake) was employed.
One of the aims of this study was to monitor a specific FA uptake which normally would require
a tag on the FA. However this may affect the uptake and metabolism of the FA as FAs are highly
sensitive to structure changes [20]. Deuteration overcomes this problem and has the added benefit
of the resultant Raman signal of CD stretches appearing in the region of 2000–2400 cm−1 where no
other biochemical information is observed. Furthermore, deuteration has minimum influence on the
metabolic pathway of the FAs. D31-PA gives the strongest signal at 2106 cm−1 which is attributed to
the νsCD2. D8-AA was also used in one of the experiments and the = CD stretch was expected to show
at 2250 cm−1. This is because D8-AA was deuterated at the unsaturated carbons in the molecule, where
D31-PA was deuterated at the saturated carbons. This results in the increase in vibration frequency
of the CD stretches in the D8-AA compared with the D31-PA [39]. However, no D8-AA signal was
detected in the Raman spectra acquired in this study. This is suspected to be due to the low Raman
sensitivity of, ν(= CD), compared to the νsCD2 signal [40]. Since these two peaks are very close to each
other and a flat baseline was not achieved in the CD stretching region, the weak ν(= CD) signal from
D8-AA appears to have been obscured by the dominant νsCD2.
Brown et al. demonstrated that omega-3 FAs have an inhibitory effect on the invasive ability of
PC-3 cells induced by AA. The invasive effect could be recovered again by the addition of downstream
AA metabolites [30,41]. However, it was not conclusive that the inhibition was due to metabolic
competition or competitive uptake. With PA, also a FA that induces metastatic effects of PC-3
cells [42,43], it is hypothesised that the uptake could be inhibited by omega-3 FAs such as DHA and
EPA. The Raman results acquired here suggest that the omega-3 FAs do inhibit the uptake of PA by
the PC-3 cells. However, the uptake of PA by the cells treated with both D31-PA and DHA shows a
different trend to the other cases. The suppression of the D31-PA uptake is much lower, and the trend
line suggests an increase in uptake after 24 h (1440 min) of treatment. This suggests the inhibitory
effect of the D31-PA uptake by DHA is less effective than EPA or AA, which is consistent with the
invasion findings by Brown et al. [30]. Similar inhibitory effects on the absorption of saturated FAs,
such as PA, brought about by EPA and DHA have also been observed by Yang et al. [44].
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From the results presented here, D31-PA can be clearly detected using Raman microspectroscopy
and trends in D31-PA uptake can be obtained under different environmental conditions. However,
large variations in the νsCD2 signal detected were found in the live-cell experiments, especially in the
later time points. Relative standard deviations (RSDs) were calculated from the cell spectra acquired.
Despite the RSD associated with D31-PA uptake at time points 90, 180 and 1440 min being 60–70%, the
RSD for the whole spectrum range is only ~4.5%. (The corresponding tables can be found in the Section
Appendix A.3.) System repeatability using polystyrene beads was determined to be greater than 99%
(Section 4.1.3), and therefore it is believed the variations observed in uptake are purely because of the
biological variances between single cells. This can be further demonstrated by the results obtained
from the experiments shown in the Section Appendix A.2, in which the entire cell was measured.
Although variations of D31-PA signal were observed due to lipid localisation, there is also significant
variation of the CD signal between cells.
The uptake of D31-PA displayed in Figure 3 generally shows a decrease after treatment of
180 min, which is believed to be attributed to the adaption of the cell to the environment as discussed
in Section 2.2. The cells were starved for 24 h in serum-free media before performing the uptake
experiment; thus depriving the cells of lipids required for survival and proliferation and ensuring a
comparable lipid baseline for all the experiments. PA can be synthesised by the cell from carbohydrates
or protein (available resources from the media) while AA can only be obtained from diet [45], cells will
only uptake the essential FAs (AA in this case) after adapting to the environment.
PA uptake by PC-3 cells under chemically induced hypoxic conditions was also studied. Some
differences in the uptake of D31-PA were observed at 30 min and at 24 h with an increase of hypoxic
uptake at 30 min but a decrease after 24 h. Bensaad et al. reported that hypoxia can induce greater
uptake of lipids from the extracellular environment where there is an increase in lipid droplets
upon HIF1-α induction without an increase in intracellular production [46]. However, this needs
further investigation.
4. Materials and Methods
4.1. Instrumentation
In this study, the BioFlux 200 shear flow assay system (Fluxion Biosciences Inc., Ca, USA)
was coupled with a customosed Raman microspectrometer and several optimisation and method
development experiments were carried out. The final system configuration is shown in Figure 4.
Figure 4a,b shows the layout of the coupled BioFlux and Raman microspectrometer and 4c,d shows
the configurations of the 48-well plates used in this study.
The BioFlux 200 contains a controller, a pressure interface, a vapour trap, pipelines for connecting
the units, and a heating plate. The controller regulates the air pressure applied to the wells and also
the heating plate temperature. Experiments were conducted in the BioFlux well plates coupled to a
Raman microspectrometer, which consists of an inverted Nikon Eclipse TE300 microscope (equipped
with a Nikon Plan Fluor 100 × oil immersion objective, Nikon UK Ltd., Surbiton, UK), a Horiba
Scientific iHR-320 Raman Imaging Spectrometer (focal length of 320 mm, f/4.1 aperture), coupled with a
Horiba Syncerity CCD camera (Horiba Scientific, Northampton, UK). A beam splitter (Edmund Optics
NT64-286), was used for guiding the 532 nm Raman laser to the sample stage and also separating the
reflected excitation laser and the Raman signal going to the spectrometer.
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Figure 4. Sche atic diagram of the system layout and equipment configuration. (a) Side view of
the configuration of the microscope and the microfluidic plate with the plate connecting to the main
body of the BioFlux system. Green arrow showing the inlet Raman laser path to the sample stage.
The area in the red rectangle is expanded in (b), which shows the configuration of the measuring unit
(BioFlux interface, the well plate, the microscope objective and a simplified light path diagram). (c)
Top-down view of the BioFlux 48-well plate configuration. (d) Layout of the microfluidic channels (one
observation unit, showing two pairs of channels, only one pair is used at a time). In the top pair the
media and FA would flow from the inlet well (designated I5) through the hairpin microfluidic channel
to the observation window containing the cells, then back out to the outlet well (designated O5). The
Raman beam would be focused on the cells in the top channel in the observation window.
4.1.1. Microfluidic evice
The BioFlux well plates re ire f r t e s ste are the size of standard 24- or 48-well plates, but
with microfluidic channels built underneath the ells. The ain body of the well plates are made of
polystyrene, while the top and the walls of the microfluidic channels are made of polydimethylsiloxane
(PDMS). Since a high numerical aperture is used for the Raman spectroscopy, the laser beam shape is
no longer collimated. Thus, there is a chance of getting some PDMS signal scattered from the top and
walls of the channel. Although PDMS is highly Raman sensitive and could potentially interfere with
the experiment, this is not a problem since the CD signals from the deuterated lipids are located in the
‘silent area’ of a Raman spectrum in which PDMS does not contribute. The dynamic flow process is
controlled through the BioFlux software, for which manual and automatic modes are available. The
air pressure can be set from 0 to 20 dyn cm−2 and the length of operating time can be pre-set for the
automatic mode. In Figure 4c, the purple shading on the well plate indicates one operation unit, with
inlet at the left hand side and outlet at the right hand side. The air pressure can be used to control flow
rate and can be applied on either the inlet or outlet side in each unit and the four units can be operated
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at the same time. Moreover, due to the pump design in the main controller, the air pressure applied
has to be the same for each of the two operation units (Column 1–4 and Column 5–8). However, length
of operation time can be varied.
A sheer flow of 0.15 dyn cm−2 was chosen for the experiment, which is high enough to enable a
continuous supply of both fresh media and FAs to the cells in the microfluidic channels but is not high
enough to cause detachment of cells from the channel surface.
A capillary structure consisting of a series of bends allows laminar flow to be developed in the
microfluidic channels as shown in Figure 4b. The solution takes a certain length of time to flow from
the inlet well to the viewing chamber (dead volume), and the time required will vary depending on the
flow rate of the solution. To determine this time, the Raman signal changes were monitored as RPMI
1640 cell culture medium was replaced by Dulbecco’s Phosphate-Buffered Saline (DPBS, Sigma-Aldrich
Inc., Poole, UK). DPBS is a physiological buffer (pH 7.1–7.5 Osmolality 275–304 mOs Kg−1) that gives
negligible fluorescence background for Raman measurements. Due to the large background intensity
differences between RPMI 1640 cell culture medium and DPBS, the total area under the Raman curves
(AUC) can be used as an indicator for determining the solution flowing in the microfluidic channels.
The results used to obtain the dead time are shown in the Section Appendix A.4.
4.1.2. Raman Microspectroscopy
To minimise the potential photodamage to the cells, it is important to consider the length of time
the cells are exposed to the laser. To obtain a reasonable signal to noise ratio (SNR), the maximum
power available from the 532 nm Raman laser at 110 mW was chosen. However, the laser power
diminishes to 41.5% of the power at source when it reaches the sample stage on the microscope.
To avoid compromising SNR and signal saturation, several integration times have been tested for
acquiring cell spectra at 110 mW at laser source. The final integration time used for all cell spectra
was 10 s. A plot of measured power density and laser output power can be found in the Section
Appendix A.5. Please note that all measurements were carried out in a DPBS background, i.e., cells in
DPBS. The corresponding cell viability test results can be found in the Section Appendix A.6. With the
integration time of 10 s, the time required for acquiring one set of data at a time point was 15–20 min.
The test results suggest that cell viability remains greater than 90% after 60 min, which is longer than
the time required for all Raman spectral acquisition at each time point. After the measurement, cells
were then exposed to culture medium again to provide materials essential for their survival.
4.1.3. System Repeatability
The repeatability of the system was tested using polystyrene beads. All measurements were taken
with Raman power of 55 mW at laser source (to avoid detector saturation) and 1 s integration time.
Two sets of experiments were conducted to test the repeatability of the system with 20 µm and 25 µm
diameter polystyrene beads:
(i) Repeat measurements on the same bead
45 measurements on the same polystyrene bead were acquired sequentially. Two more replicates
were obtained by moving the laser beam away from the bead for a few minutes, then returning to
the same bead again for another 45 measurements. This experiment was repeated for three times i.e.,
three replicates.
(ii) Repeat measurements on different beads
45 different beads were measured sequentially. Three replicates were taken, i.e., the experiment was
repeated three times, but beads measured are not necessarily the same beads among the three replicates.
Figure 5 plots all the mean spectra of the three replicates of the experiments. In each case, there
were 45 measurements and therefore there are 540 measurements in total. As can be seen there is
almost perfect overlap between spectra. To observe marginal spectral differences, two sections have
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been significantly expanded and are shown in the insert in Figure 5 Standard deviations (SD) of the
AUCs, mean AUC and relative standard deviations of the AUCs were then calculated. An average
RSD of 0.94% was obtained from all 12 experiments indicating that the Raman microspectrometer
system produces stable performance and gives high repeatability (>99%). This confirms that variances
obtained in experiments involving cells are caused by biological differences.
Molecules 2019, 24, x FOR PEER REVIEW 11 of 23 
 
almost perfect overlap between spectra. To observe marginal spectral differences, two sections have 
been significantly expanded and are shown in the insert in Figure 5 Standard deviations (SD) of the 
AUCs, ean AUC and relative standard deviations of the AUCs were then calculated. An average 
 f 0.94% was obtained from all 12 experim nts indicating that the Raman microspectrometer 
 s  ce  i  hig  repeata  (> ). i  fi s t  
variances obtained in experiments involving cells are caused by biological differences.  
 
Figure 5. System repeatability test results and the corresponding statistical test results showing the 
mean spectra of all 12 polystyrene bead experiments. All 12 mean spectra generated from 540 single 
bead spectra overlay with each other in the figure, showing that there are negligible differences 
between the Raman spectra measured in different situations. The calculated relative standard 
deviations of each case and the calculated average RSD is only 0.94%. The inserts show the peaks at 
1442 and 1145 cm−1 in order to better highlight the individual spectra. 
4.2. Cell Culture 
The PC-3 cells were first cultured in standard culturing flasks in Ham’s F12 cell culture medium 
(Sigma-Aldrich Inc.), 10% foetal bovine serum (FBS, Sigma-Aldrich Inc.), 1% L-glutamine (Sigma-
Aldrich Inc.) and 1% penicillin/streptomycin (Sigma-Aldrich Inc.) until 70% confluency. Cells were 
pre-seeded into the channels at a concentration of 2 × 107 cells mL−1 two days prior to the experiment 
to allow adhesion before treatment. Cells were seeded from the outlet side of the channel to prevent 
any contamination of the inlet channel at a sheer flow of 2 dyn cm−2 for 5 s. During these primary cell 
culture times, the cells were incubated at 37 °C with 5% CO2 supply in air. 
Before applying any treatment to the cells under normoxic conditions (oxygen concentration in 
a normoxic incubator is 18.6%, at sea level [32]) in microfluidic channels, the cells were starved in 
serum-free RPMI 1640 medium (Sigma-Aldrich Inc.), 1% L-glutamine and 1% penicillin/streptomycin 
for 24 h. During the starvation period, the cells were also incubated at 37 °C with 5% CO2 supply in 
air.  
In this work hypoxia was chemically induced with cobalt (II) chloride (CoCl2, Sigma-Aldrich 
Inc., Poole, UK) dissolved in distilled water [47]. 100 µM of CoCl2 was added to the serum-free 
medium and the cells were starved and incubated with the CoCl2 for 24 h before the lipid uptake 
experiment. The induction of hypoxia in these cells was validated using Image-iT™ Red Hypoxia 
Figure 5. System repeatability test results and the corresponding statistical test results showing the
mean spectra of all 12 polystyrene bead experiments. All 12 mean spectra generated from 540 single
bead spectra overlay with each other in the figure, showing that there are negligible differences between
the Raman spectra measured in different situations. The calculated relative standard deviations of each
case and the calculated average RSD is only 0.94%. The inserts show the peaks at 1442 and 1145 cm−1
in order to better highlight the individual spectra.
4.2. Cell Culture
he PC-3 cells were first cultured in standard culturing flasks in Ham’s F12 cell culture
medium (S gma-Aldrich Inc.), 10% fo tal bovine serum (FBS, Sigma-Aldrich Inc.), 1% L-glutamine
(Sigma-Aldrich Inc.) and 1% penicillin/streptomycin (Sigma-Aldrich Inc.) until 70% confluency. Cells
were pre-seeded into the channels at a concentration of 2 × 107 cells mL−1 two days prior to the
experiment to allow adhesion before treatment. Cells were seeded from the outlet side of the channel
to prevent any contamination of the inlet channel at a sheer flow of 2 dyn cm−2 for 5 s. During these
primary cell culture times, the cells were incubated at 37 ◦C with 5% CO2 supply in air.
Before applying any treatment to the cells under normoxic conditions (oxygen concentration in
a normoxic incubator is 18.6%, at sea level [32]) in microfluidic channels, the cells were starved in
se um-free RPMI 1640 medium (Sigma-A drich Inc.), 1% L-glutamine and 1 penicillin/streptomycin
fo 24 h. During the starvation period, the cells were also incubated at 37 ◦C with 5% CO2 supply in air.
In this ork hypoxia was chemically induced with cobalt (II) chloride (CoCl2, Sigma-Aldrich Inc.,
Poole, UK) dissolved in distilled water [47]. 100 µM of CoCl2 was added to the serum-free medium
and the cells were starved and incubated with the CoCl2 for 24 h before the lipid uptake experiment.
The induction of hypoxia in these cells was validated using Image-iT™ Red Hypoxia Reagent (Thermo
Fisher Scientific UK Ltd. Hemel Hempstead, UK), a reversible fluorescent dye for measuring hypoxia
in live cells. This reagent works based on the intracellular oxygen level which is non-fluorescent when
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the intracellular oxygen level is above 5% and becomes fluorescent (in red) when the intracellular
oxygen level is below 5%. The results of these experiments are described in the Section Appendix A.7.
4.3. Fatty Acid Treatments
Several treatments were applied in different experiments to study the competition between the
D31-PA with other fatty acids (FA). All FAs used in this project were obtained in either powder or neat
oil form. Ethanol (≥ 98%, Thermo Fisher Scientific UK Ltd. Hemel Hempstead, UK) was chosen as
the vehicle to make the FAs available to the cells. The concentrations used for each FA was 20 µM in
serum-free RPMI 1640 cell culture medium with 1% L-glutamine and 1% penicillin/streptomycin. The
cells were treated with either: D31-PA only, D31-PA and DHA, D31-PA and EPA, and D31-PA and
D8-AA in each experiment (all FAs are from Sigma-Aldrich Inc., Poole, UK).
The FA-containing RPMI 1640 cell culture medium (with 1% L-glutamine and 1%
penicillin/streptomycin for all experiments, and 100 µM CoCl2 for hypoxia experiment) is supplied
to the cells by constantly applying 0.15 dyn cm−2 sheer flow to the inlet during the experiment,
except during the Raman spectra measurements. At each time point, the solution was then switched
to DPBS at the same flow rate until the viewing chamber was fully replaced with DPBS. After the
measurement, the solution was then switched back to the FA-containing medium for further treatment.
Approximately 45 cells were sampled at each time point: t = 0, 15, 30, 45, 60, 90, 180 and 1440 min.
4.4. Data Processing and Analysis
One-to-one background subtraction was applied to each cell spectrum (SynerJY version 3.5.7.20).
All the cell spectra were imported into MATLAB 2017a for further processing including removal
of any contributions from cosmic rays. 3-point smoothing with a moving mean method (chosen to
minimise the effect of peak shifts), linear baseline correction and vector normalisation were applied.
With the 1200 lines per mm grating used in this project, the Raman shift is available from range 671
to 2430 cm−1. However, the Raman shift range is purposely reduced to 2082–2136 cm−1 for monitoring
the νsCD2 stretch from the D31-PA. The relative uptake of the D31-PA is quantified by calculating the
area under the curves in this range after 2-point rubber band correction at first and last point of the
spectra. Uptake curves of the experiments were plotted with the mean spectral area under this peak.
5. Conclusions
This work demonstrates the novel combination of coupling the BioFlux microfluidic system with
a Raman microspectrometer in order to spectroscopically study biological systems under dynamic
flow. With the increase in importance of studying the biology of living cells under their natural
environment, development of dynamic flow systems help to simulate physiological conditions. The
use of isotopically labelled fatty acids enabled monitoring of the uptake of a specific type of fatty acid
by analysis of CD peaks in the Raman spectra. With the combination of this instrumentation and
isotopically labelled reagents, continuous chemical monitoring in living cells at the single-cell level can
be performed.
This study also demonstrates analysis of cells under different conditions such as normoxic and
hypoxic states. This is a key factor in single cell studies since physiological conditions, particularly in
tumours, are often highly hypoxic but most studies are carried out under in-vitro normoxic conditions.
Author Contributions: N.-T.T. performed the bulk of the experimental work and wrote the main body of the
manuscript. J.L.D. initiated the collaboration with Fluxion and J.L.D. and P.G. supervised the project and handled
logistics. N.-T.T., J.L.D. and P.G. were equally involved in experimental design. M.D.B. was involved in the
conceptual design of the fatty acid uptake experiments and contributed to the writing of the manuscript. R.D.S.
was involved in experimental design and contributed extensive input into Raman instrument configuration.
B.A.H. contributed training, technical support and scientific input into hypoxia experiments. A.R. provided the
loan of the BioFlux instrument. All authors contributed to the writing of the paper and approve this version. All
authors have read and agreed to the published version of the manuscript.
Funding: This research received no external funding.
Molecules 2020, 25, 1652 13 of 23
Acknowledgments: Lebtech International Ltd. and Fluxion Biosciences, Inc. are acknowledged for loan of the
BioFlux200 and technical support.
Conflicts of Interest: The authors declare no conflict of interest.
Appendix A
Appendix A.1 Example Cell Image Taken under the Microscope
Cells under the microscope are shown in Figure A1. During the measurements, the Raman laser
was positioned onto the centre of each cell to acquire single cell spectra.
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Figure A1. Example image of PC-3 cells cultured inside the microfluidic channel.
pendix A.2 Additional Data on the 5-Point Measurements
As described in Section 4.1.3, the system repeatability was confirmed non-biologically using
polystyrene beads and it is believed that the variations observed are purely because of the biological
variances between single cells. This was further investigated with ‘five-poi t measurements’ a d
the results suggest that the more likely cause of variation in the data is the localisation f lipid
droplets within the cells. Results of the ‘five-point measurements’ are shown in, where cells were
treated with 20 µM D31-PA. The five measurements at eac location ensured that the whole cell was
completely sampled.
The areas under the CD peak, plotted against the correspon ing sequence number, are shown in
Figure A2a–c. A representative plot of the D31-PA signal acquired at each point in a cell at t = 60 min is
shown in Figure A2d. The locations of the five spectra obtained for each cell are indicated in Figure A2e.
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Figure A2. Distribution of the amount of lipid taken up by cells. Top row showing the example
single point results of area under the curve against corresponding event number for cells treated with
D31-PA only under normaoxic conditions, at time point (a) 90 min, (b) 180 min, and (c) 1440 min.
(d) Representative plot for the area under the 2106 cm−1 peak at the five measurement locations in
each cell at t = 60 min. (c) Corresponding schematic of the locations of the five measurements taken in
the experiment.
During the experiment, five spectra per cell were taken with 10 s of integration time. Taking the
operation time into account, the total laser exposure time per cell was ~1 min. As shown inFigure A2d,
the area under the peak measured at the five locations in each cell are different, which reflects the
localisation of the lipid droplets. This may be one of the contributions to the large variance observed at
later time points in the lipid uptake experiments where the Raman laser might have just hit or missed
the lipid droplet. In addition to the variations within each cell, variations between different cells were
also observed. From Figure A2b, it is clear that some of the cells give larger νsCD2 signal than the
others indicating that different cells uptake the D31-PA at different rates.
Appendix A.3 Statistical Significance for the Uptake Experiments
Results obtained were statistically analysed where the relative standard deviations (RSD) were
calculated for assessing the variance. The calculated values are shown Tables A1 and A2 for the area
under the 2106 cm−1 CD peak and the area under the full spectrum respectively.
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Table A1. RSD calculated in the D31-PA uptake (2106 cm 1 peak only).
RSD/%
0 min 15 min 30 min 45 min 60 min 90 min 180 min 1440 min
D31-PA 32.1 32.5 40.1 46.1 54.1 56.4 69.9 65.2
vs. DHA 27.2 35.2 29.4 31.4 63.3 51.1 56.9 84.9
vs. EPA 40.3 33.3 36.2 29.2 33.8 41.6 54.0 49.3
vs. AA 32.1 34.8 61.9 61.2 86.1 78.1 63.2 51.2
D31-PA
(Hypoxic) 32.7 39.1 62.3 64.1 63.0 76.5 69.9 90.9
Ctrl 35.1 34.8 28.5 33.7 35.3 37.8 35.3 44.0
Table A2. RSD calculated in the full spectral region.
RSD/%
0 min 15 min 30 min 45 min 60 min 90 min 180 min 1440 min
D31-PA 3.08 2.59 2.73 2.61 2.47 4.08 5.15 4.22
vs. DHA 2.91 2.48 3.08 3.61 3.16 2.56 3.43 4.38
vs. EPA 2.09 1.94 3.55 3.11 3.33 2.94 3.23 2.30
vs. AA 3.21 4.16 2.57 2.51 3.08 3.30 2.87 2.99
D31-PA
(Hypoxic) 4.03 3.10 2.46 3.32 3.85 6.02 6.34 11.5
Ctrl 2.91 3.39 3.51 2.46 2.67 3.21 3.41 3.47
Two-tailed t-test was also used to evaluate the statistical significance of the uptake of D31-PA by
PC-3 cells compared to the control experiment. The null hypothesis is that the uptakes of D31-PA
by PC-3 cells are the same between treated and control experiments. The p value for each case was
calculated and any p value that is greater than the critical value will reject the null hypotheses i.e., there
are significant differences between the two sets of data. p values for all cases are shown in Table A3.
Table A3. The p values of the two-tailed t-tests comparing the uptake of D31-PA in the control
experiment with other treatments. * is significant at 0.05 confidence level and ** is at 0.01 confidence
level. n values are shown in the brackets.
p Value Control
0 min 15 min 30 min 45 min 60 min 90 min 180 min 1440 min
vs. D31-PA
(Normoxic)
0.998
(98)
0.012
(93) *
<0.001
(92) **
<0.001
(94) **
<0.001
(95) **
<0.001
(95) **
<0.001
(94) **
<0.001
(91) **
vs. DHA 0.543(98)
<0.001
(88) **
<0.001
(97) **
<0.001
(95) **
<0.001
(90) **
<0.001
(92) **
<0.001
(89) **
<0.001
(96) **
vs. EPA 0.013(99)
0.272
(93)
<0.001
(97) **
0.025
(90) *
<0.001
(94) **
<0.001
(96) **
<0.001
(100) **
<0.001
(96) **
vs. AA 0.769(96) *
<0.001
(99) **
<0.001
(99) **
<0.001
(98) **
<0.001
(94) **
<0.001
(104) **
<0.001
(93) **
<0.001
(98) **
vs. D31-PA
(Hypoxic)
0.942
(99)
<0.001
(96) **
<0.001
(96) **
<0.001
(96) **
<0.001
(97) **
<0.001
(99) **
<0.001
(100) **
<0.001
(98) **
Appendix A.4 Biological Optimisation of the System: Flow Rate and Background Test
The intensity differences between the Dulbecco’s Phosphate-Buffered Saline (DPBS) and the RPMI
1640 media are shown in Table A3a.
Figure A3a plots the area under each spectrum shown in Figure A3b against time and shows
that the actual time required for replacing one solution in the channel with other solution is 105 s.
The time-limiting step of the whole process is to remove the dead volume in the capillary structure.
The area under the curve flattens out and remains constant at 450 s in Figure A3a, which indicates
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the media filled channel is fully replaced with DPBS at this point. This was taken into account when
performing the time point experiments.
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pure RPMI 1640 and the lowest is the pure DPBS.
Appendix A.5 Relative Raman Laser Power Ratio Measurement Results
To obtain a measure of how much power loss occurs between the laser source and the objective,
th relative power was measu ed at the two locations u ing an EG & G 550-1 Radiometer/Photometer
equipped with an EG & G 550-2 multiprobe detector. For health and safety reasons and in order to
make sure that the detector was operating in the linear range, an optical density (OD) 2.0 filter was
placed in front of the laser source for the power density measurement. Please note that, since the
area of the detector is significantly larger than the laser beam, it is just the relative power between
the two locations that is of significance. Data were recorded up to a laser source setting of 40 mW as
shown in Figure A4. Extrapolating this data to 110 mW we obtain a power at the objective of ~45 mW.
Although this is quite high, the possibility of photodamage has been investigated in a similar Raman
setup previously by Harvey et al. [48]. The results show that using 27.5 mW of 514.5 nm focused laser
irradiation, caused minimal damage to cells up to an exposure time of 30s. Therefore, in this current
study, the selected integration of 10 s suggests minimal photodamage to the cells using this system.
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Appendix A.6 Cell Viability in Room Temperature DPBS
During the five-point measurements, cells were in DPBS for an hour. The cell viability was tested
with a trypan blue assay and pictures were taken under a microscope every 30 min with a 5 × objective,
which are shown in Figure A5.
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Cell viability after 60 min room temperature DPBS exposure was counted by using Trypan blue
assay. Automatic cell counter (Cellometer Auto 1000 Cell Viability Counter, Nexcelom Bioscience Ltd.,
Manchester, UK) was used and the results are shown in Table A4.
Table A4. The cell viabilities (in percentage) obtained.
Sample 1 Sample 2 Sample 3 Average
90.9% 88% 94.1% 91.0%
Appendix A.7 Monitoring the Change of States of Cells Using Hypoxic Reagent
Experiments were conducted to ensure the cells were under hypoxia after treating them with
100 µM cobalt (II) chloride (CoCl2, Sigma-Aldrich, Inc., Poole, UK) for 24 h. A solution of 5 µM ImageIT
(concentration suggested by the supplier’s standard procedures, Thermo Fisher Scientific UK Ltd.
Hemel Hempstead, UK) was used for monitoring the changes in cell condition. This florescence dye
works based on the intracellular oxygen level of the cells which will turn red if the intracellular oxygen
level is below 5%. The dye is reversible and is transparent when intracellular oxygen level is increased
to 5% or higher.
Cells were seeded into the BioFlux plate two days beforehand allowing them to attach and develop.
Standard procedures used for seeding cells into the well plate are described in Section 4.2. Serum-free
FluoroBrite with both ImageIT and CoCl2 added as supplement were used for treating the cells. Images
were taken at the 0 time point and 24 h time point.
Figure A6 shows the example images taken at 0 and 24 h of treatment of one of the microfluidic
channels. It can be seen that most of the cells turned hypoxic after 24 h of treatment. Bright field
images are also included for locating the cells.
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During the Raman measurements, DPBS was used, and therefore it was important to ensure the
cells did not switch back to normoxic state during the measurement period.
With 10 s of integration time for each cell and 50 cells per measurement, total DPBS exposure
time for one time point was approximately 20–25 min. The fluid in the microfluidic channels was
then switched back to the serum-free RPMI containing CoCl2 to ensure that the hypoxic condition
was maintained. To monitor the effect of DPBS on the cells condition, experiments were performed by
exposing cells under hypoxia (treated with CoCl2 for 24 h prior) in DPBS for 30 min. ImageIT reagent
was used to monitor the condition of cells throughout the experiment.
Figure A7 shows the dark field image of the same area in a channel of cells exposed to DPBS for 0,
10, 20 and 30 min. It is clear that the cells had not switched back into a normoxic state after 30 min.
Although measurements were expected to be completed within 30 min per time point, one further
time point at 60 min was imaged. A dark field microscope picture is shown in Figure A8 which shows
that the cells were still in a hypoxic state after 60 min of fresh DPBS exposure.
Figure A7. Dark field microscope images for the cells in a hypoxic state exposed to DPBS. (a) Image
taken at 0 min. (b) Image taken at 10 min. (c) Image taken at 20 min. (d) Image taken at 30 min.
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